Article Information
History
- February 7, 2022.
Article Versions
- Version 1 (February 4, 2022 - 22:42).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Pierre-Philippe Piché-Renaud, MD1,*,
- Luc Panetta, MD2,3,*,
- Daniel S. Farrar, MPH4,
- Charlotte Moore-Hepburn, MD5,6,7,
- Olivier Drouin, MDCM MSc MPH8,9,
- Jesse Papenburg, MD MSc10,11,12,
- Marina I. Salvadori, MD10,13,
- Melanie Laffin14,
- Fatima Kakkar, MD MPH#,3,†,
- Shaun K. Morris, MD MPH#,1,4,7,15,†,
- the Canadian Paediatric Surveillance Program COVID-19 Study Team
- 1Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Canada
- 2Paediatric Emergency Department, Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Lyon, France
- 3Division of Infectious Diseases, CHU Sainte-Justine, Montreal, Canada
- 4Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada
- 5Division of Paediatric Medicine, The Hospital for Sick Children, Toronto, Canada
- 6Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
- 7Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada
- 8Division of General Pediatrics, Department of Pediatrics, CHU Sainte-Justine, Montreal, Canada
- 9Department of Social and Preventive Medicine, School of Public Health, Université de Montréal, Montréal, Canada
- 10Division of Pediatric Infectious Diseases, Department of Pediatrics, The Montreal Children’s Hospital, McGill University Health Centre, Montreal, Quebec, Canada
- 11Division of Medical Microbiology, Department of Clinical Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada
- 12Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
- 13Public Health Agency of Canada, Ottawa
- 14Canadian Paediatric Surveillance Program
- 15Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
- ↵†Corresponding authors:
Shaun K. Morris, Division of Infectious Diseases, The Hospital for Sick Children, 555, University Ave, Toronto, ON, M5G 1X8, Canada. Email: shaun.morris{at}sickkids.ca. Phone: 416-813-6625; Fax: 416-813-8404, Fatima Kakkar, Division of Infectious Diseases, Centre Hospitalier Universitaire Sainte-Justine, 3175 Chemin Cote Sainte-Catherine, Montreal, QC, H3T 1C5, Canada. Email: fatima.kakkar{at}umontreal.ca. Phone: 514-345-4931 x6885
Posted February 07, 2022.
Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada
